Latest News for: cgx

Edit

Congruence Therapeutics to Present Preclinical Characterization of its MC4R Corrector Development Candidate CGX-926 for Genetic ...

Citizen Tribune 06 Nov 2025
– Presentation highlights in vitro activity across a spectrum of clinically-relevant variants as well as in vivo reduction of body weight and hyperphagia in MC4R-deficient Mutant Mice – ....
Edit

Congruence Therapeutics to Present Preclinical Characterization of its MC4R Corrector Development Candidate CGX-926 for Genetic Obesity at ObesityWeek 2025

PR Newswire 06 Nov 2025
"Our findings demonstrate that CGX-926 pharmacologically stabilizes misfolded receptors, restores normal signaling, and reduces body weight and hyperphagia in animal models ... Title. "CGX-926, a ...
Edit

Press Release - CGX Loan (CGX Energy Inc)

Public Technologies 04 Nov 2025
) ‌CGX Energy Files Second Quarter Financial Statements, Announces Impairment of the Corentyne Block, and Changes to the Board of Directors. Toronto, Canada, August 13, 2025 - CGX Energy Inc ... ("Frontera Guyana") and CGX Resources Inc.
  • 1

Article Search

tools
×
×
×
×